forward-looking statements that
reflect Watson's current perspective of existing trends and information as
of the date of this release. Except as expressly required by law, Watson
disclaims any intent or obligation to update these forward-looking
statements. Actual results may differ materially from Watson's current
expectations depending upon a number of factors affecting Watson's
business. These factors include, among others, difficulties or delays in
transferring product manufacturing to the Goa facility; difficulties or
delays in obtaining U.S. Food and Drug Administration or other regulatory
approvals to manufacture products at the Goa, India site for the U.S.
market; the impact of competitive products and pricing; market acceptance
of and continued demand for Watson's products; difficulties or delays in
manufacturing; and other risks and uncertainties detailed in Watson's
periodic public filings with the Securities and Exchange Commission,
including but not limited to Watson's Annual Report on Form 10-K for the
year ended December 31, 2006.